IN2009DE02299A - - Google Patents

Download PDF

Info

Publication number
IN2009DE02299A
IN2009DE02299A IN2299DE2009A IN2009DE02299A IN 2009DE02299 A IN2009DE02299 A IN 2009DE02299A IN 2299DE2009 A IN2299DE2009 A IN 2299DE2009A IN 2009DE02299 A IN2009DE02299 A IN 2009DE02299A
Authority
IN
India
Prior art keywords
pharmaceutical formulation
present
inhalation
preventing
heavy metal
Prior art date
Application number
Other languages
English (en)
Inventor
Aseem Bhatnagar
Farhan Jalees Ahmad
Neeraj Kumar
Shaheen Sultana
Gaurav Mittal
Rashid Ali
Original Assignee
Director General Defence Res & Dev Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Director General Defence Res & Dev Org filed Critical Director General Defence Res & Dev Org
Priority to IN2299DE2009 priority Critical patent/IN2009DE02299A/en
Publication of IN2009DE02299A publication Critical patent/IN2009DE02299A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2299DE2009 2009-11-09 2009-11-09 IN2009DE02299A (cg-RX-API-DMAC10.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2299DE2009 IN2009DE02299A (cg-RX-API-DMAC10.html) 2009-11-09 2009-11-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2299DE2009 IN2009DE02299A (cg-RX-API-DMAC10.html) 2009-11-09 2009-11-09

Publications (1)

Publication Number Publication Date
IN2009DE02299A true IN2009DE02299A (cg-RX-API-DMAC10.html) 2015-07-31

Family

ID=54396544

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2299DE2009 IN2009DE02299A (cg-RX-API-DMAC10.html) 2009-11-09 2009-11-09

Country Status (1)

Country Link
IN (1) IN2009DE02299A (cg-RX-API-DMAC10.html)

Similar Documents

Publication Publication Date Title
US20090298802A1 (en) Pharmaceutical Compositions
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
JP2019517597A5 (cg-RX-API-DMAC10.html)
GEP20063876B (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
ECSP14018630A (es) Formulaciones farmacéuticas novedosas
WO2007123955A3 (en) Stable hydroalcoholic oral spray formulations and methods
TW200500098A (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
MX2009000849A (es) Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas.
AU2003291497A1 (en) The use of an anti-allergy agent and a steroid to treat allergic rhinitis
DE60216588D1 (de) Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
HRP20220929T3 (hr) Sastav za inhalaciju koji sadrži aklidinij za liječenje astme
AR055363A1 (es) Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion
TNSN06277A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
MX2017004476A (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion.
TW202110452A (zh) 以組蛋白去乙醯酶抑制劑治療病毒相關癌症之方法
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
EP1993567A4 (en) PER OS ADMINISTRABLE GALLIUM PREPARATIONS AND METHODS OF USE
JP2008501655A5 (cg-RX-API-DMAC10.html)
ZA200709296B (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
TNSN05048A1 (en) Inhalation compositions with high drug ratios
JP2014534215A5 (cg-RX-API-DMAC10.html)
JP2011111418A (ja) 口腔内局所投与に適したウイルス感染予防製剤
US20230158067A1 (en) Silver nanoparticles for use in inhibiting and treating coronavirus infection
SG159550A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent